Jeffrey Hammerbacher has charted a course from Bear Stearns in 2005 to Facebook in 2006 to Cloudera in 2008, notes Steve Lohr in an adapted excerpt from his book Data-ism: The Revolution Transforming Decision Making, Consumer Behavior, and Almost Everything Else appearing in the New York Times. At each point along the way Hammerbacher has used math and data science, tools he's now applying to medicine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.